Skip to Content
Author: The BCW

Leave a Comment

Regeneron Gets FDA Approval for EYLEA’s Pediatric Treatment

In another breakthrough for BCW Member Regeneron Pharmaceuticals, the U.S. Food and Drug Administration (FDA) has approved the company’s EYLEA® (aflibercept) Injection to treat preterm infants with retinopathy of prematurity (ROP). Following this first pediatric approval, EYLEA is now indicated to treat five retinal conditions caused by ocular angiogenesis.

“Retinopathy of prematurity is a leading cause of childhood blindness worldwide. Until now, the only FDA-approved treatment in common use was laser photocoagulation, a complex and lengthy procedure that permanently ablates retina tissue and is stressful not only for infant patients but also the family navigating a delicate time after a preterm birth,” said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron, and a principal inventor of EYLEA. “For the first time, physicians will now have an FDA approved medication in EYLEA to treat this heartbreaking disease in these smallest of patients. We thank the investigators and the many families who participated in the clinical trials.”

Each year in the U.S., between 1,100 to 1,500 infants develop ROP that is severe enough to require medical treatment. This rare eye disease often impacts infants who are born before 31 weeks of pregnancy have been completed or who weigh less than 3.3 lbs pounds at birth. “Regeneron’s trials investigating EYLEA in retinopathy of prematurity have advanced our understanding of how to treat this disease and provided a needed evidence-based treatment option to potentially help preterm infants preserve their vision,” said Jeff Todd, Chief Executive Officer of Prevent Blindness.

EYLEA is being jointly developed by Regeneron and Bayer.

Similar News Items

More than 125 BCW members and guests enjoyed a delightful and relaxing day of golf, tennis, recharging and refreshing at the BCW’s Day of Wellness held May 19 at the Scarsdale Golf Club. The Presenting Sponsor for the all-day event was HSS. The day’s activities included a Health Fair, Brunch, Golf Tournament, Spa Services, Yoga, […]

Read Article

BCW Member Balancing Life’s Issues (BLI), a national leader in corporate wellness and work-life integration training, has announced its successful recertification as a Certified B Corporation, proving once again that doing business ethically, sustainably, and with heart is not just possible — it’s essential. The B Corp recertification process demands rigorous transparency, data tracking, and proof […]

Read Article

The Business Council of Westchester is among a coalition of 20 business organizations representing tens of thousands of businesses of all sectors and sizes across New York, which is requesting rejection of proposed legislation that would dramatically increase short-term disability benefits. According to a letter from the coalition to House Speaker Carl Heastie and the […]

Read Article

Become A Member

Join the county’s largest and most influential business organization today.

JOIN NOW!
The Business Council of Westchester is committed to helping businesses market, learn, advocate, and grow. Over 80 events and programs are offered every year, giving our members ample opportunity to connect and meet with businesses representatives in the Westchester community and beyond.
Back to top